Masimo Corporation (MASI) - Total Liabilities
Based on the latest financial reports, Masimo Corporation (MASI) has total liabilities worth $977.70 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Masimo Corporation - Total Liabilities Trend (1998–2025)
This chart illustrates how Masimo Corporation's total liabilities have evolved over time, based on quarterly financial data. See Masimo Corporation current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Masimo Corporation Competitors by Total Liabilities
The table below lists competitors of Masimo Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Affiliated Managers Group Inc
NYSE:AMG
|
USA | $4.39 Billion |
|
Puig Brands SA
MC:PUIG
|
Spain | €4.64 Billion |
|
Compeq Manufacturing Co Ltd
TW:2313
|
Taiwan | NT$42.71 Billion |
|
Hainan Airlines Co Ltd A
SHG:600221
|
China | CN¥143.12 Billion |
|
Krka d. d
WAR:KRK
|
Poland | zł665.51 Million |
|
Hangzhou Silan Microelectronics Co Ltd
SHG:600460
|
China | CN¥12.33 Billion |
|
Autoliv Inc
ST:ALIV-SDB
|
Sweden | Skr5.86 Billion |
|
Chart Industries Inc
NYSE:GTLS
|
USA | $6.42 Billion |
Liability Composition Analysis (1998–2025)
This chart breaks down Masimo Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Masimo Corporation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.36 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.58 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Masimo Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Masimo Corporation (1998–2025)
The table below shows the annual total liabilities of Masimo Corporation from 1998 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $977.70 Million | -37.88% |
| 2024-12-31 | $1.57 Billion | -6.14% |
| 2023-12-31 | $1.68 Billion | -10.42% |
| 2022-12-31 | $1.87 Billion | +455.73% |
| 2021-12-31 | $336.80 Million | +10.46% |
| 2020-12-31 | $304.91 Million | +33.58% |
| 2019-12-31 | $228.25 Million | +22.88% |
| 2018-12-31 | $185.75 Million | +2.39% |
| 2017-12-31 | $181.41 Million | -30.30% |
| 2016-12-31 | $260.29 Million | -20.16% |
| 2015-12-31 | $326.02 Million | +26.73% |
| 2014-12-31 | $257.26 Million | +129.17% |
| 2013-12-31 | $112.26 Million | +13.40% |
| 2012-12-31 | $98.99 Million | +14.52% |
| 2011-12-31 | $86.44 Million | +7.78% |
| 2010-12-31 | $80.20 Million | +20.31% |
| 2009-12-31 | $66.66 Million | -9.74% |
| 2008-12-31 | $73.85 Million | -13.57% |
| 2007-12-31 | $85.44 Million | -16.32% |
| 2006-12-31 | $102.11 Million | -49.37% |
| 2005-12-31 | $201.67 Million | +29.45% |
| 2003-12-31 | $155.79 Million | +17.32% |
| 2002-12-31 | $132.79 Million | +2503.80% |
| 1999-12-31 | $5.10 Million | +59.38% |
| 1998-12-31 | $3.20 Million | -- |
About Masimo Corporation
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET pla… Read more